28/04/2017 The Board of Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, announces that Dr John Hughes, non-executive Chairman, has taken leave of absence in order to undergo medical treatment. Russell King, Senior Independent Director, will assume the Chair until John’s return or the appointment of his successor on completion of the... Read more
By Lynn Adler and Jonathan Schwarzberg NEW YORK, April 28 (Reuters) – US companies have lined up at least US$42.5bn of loans to back a flurry of mergers in sectors ranging from healthcare to food and software in the second quarter as corporations try to grow by acquisition. Becton Dickinson’s US$24bn takeover of C R... Read more
Investors are always looking for stocks that are poised to beat at earnings season and Becton, Dickinson and Company BDX may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Becton is seeing favorable earnings estimate revision activity as... Read more
Basel, 28 April 2017 Invitation to Roche Analyst Event at ASCO 2017 Monday, 5 June 2017, 5:15pm CDT We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (2 – 6... Read more